Abstract
Rational emotive behavioral therapy (REBT) is a form of cognitive behavioral therapy developed by Albert Ellis. Developed in the 1950s, REBT was one of the earliest forms of what became known as cognitive behavioral therapy. It was successfully adapted for children and adolescents in the 1980s (Barnard & Joyce, 1984) and has been studied extensively and shown to be effective in this population (Gonzales, Nelson, & Gutkin, 2004). This article provides a selective review of the literature, and brief overview of REBT, and discusses its advantages and disadvantages.
Keywords: Rational emotive behavioral therapy, Albert Ellis, children and adolescents, review, neurotic behaviors, maladaptive, supportive therapy, psychoanalytically-oriented therapy, Alzheimer's disease
Adolescent Psychiatry
Title: Albert Ellis Rational-Emotive Behavior Therapy
Volume: 1 Issue: 1
Author(s): Richard Rosner
Affiliation:
Keywords: Rational emotive behavioral therapy, Albert Ellis, children and adolescents, review, neurotic behaviors, maladaptive, supportive therapy, psychoanalytically-oriented therapy, Alzheimer's disease
Abstract: Rational emotive behavioral therapy (REBT) is a form of cognitive behavioral therapy developed by Albert Ellis. Developed in the 1950s, REBT was one of the earliest forms of what became known as cognitive behavioral therapy. It was successfully adapted for children and adolescents in the 1980s (Barnard & Joyce, 1984) and has been studied extensively and shown to be effective in this population (Gonzales, Nelson, & Gutkin, 2004). This article provides a selective review of the literature, and brief overview of REBT, and discusses its advantages and disadvantages.
Export Options
About this article
Cite this article as:
Rosner Richard, Albert Ellis Rational-Emotive Behavior Therapy, Adolescent Psychiatry 2011; 1 (1) . https://dx.doi.org/10.2174/2210676611101010082
DOI https://dx.doi.org/10.2174/2210676611101010082 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Small Heat Shock Proteins and Protein-Misfolding Diseases
Current Pharmaceutical Biotechnology Patient Radiation Doses in Interventional Cardiology Procedures
Current Cardiology Reviews Toxic Epidermal Necrolysis and Antifolate Drugs in Cancer Chemotherapy
Current Drug Safety Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders
Current Pharmaceutical Design Anti-inflammatory Potential of GSK-3 Inhibitors
Current Drug Targets Cancer Diagnosis and Treatment Guidance: Role of MRI and MRI Probes in the Era of Molecular Imaging
Current Pharmaceutical Biotechnology Regulators of Stem Cells Proliferation in Tissue Regeneration
Current Stem Cell Research & Therapy Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Current Pharmaceutical Design Novel Biomarkers for Lupus Nephritis in the “OMICS” Era
Current Medicinal Chemistry Functions of Ghrelin in Brain, Gut and Liver
CNS & Neurological Disorders - Drug Targets An Effective Vaccination Approach Augments Anti-HIV Systemic and Vaginal Immunity in Mice with Decreased HIV-1 Susceptible α4β7high CD4+ T Cells
Current HIV Research Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Current Gene Therapy The Role of the Calcium-Sensing Receptor in Human Pathophysiology
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Potential of Tetrandrine Against Gliomas
Anti-Cancer Agents in Medicinal Chemistry Cytotoxic and Allergenic Potential of Bioactive Proteins and Peptides
Current Pharmaceutical Design Searching for Therapeutics Against Botulinum Neurotoxins: A True Challenge for Drug Discovery
Current Topics in Medicinal Chemistry Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Immunotherapeutic and Immunoregulatory Drugs in Haematologic Malignancies
Current Topics in Medicinal Chemistry